DALLAS – Dec. 23, 2024 – UT Southwestern Medical Center researchers identified a genetic mutation that slows the growth of melanoma and potentially other cancers by harnessing the power of the immune system.
Health Professionals
Prophylactic Tocilizumab Reduces Toxicity, Boosts Efficacy in Immune Checkpoint Inhibitor–Treated Melanoma
Matthew Hadfield, DO, discusses findings from a phase 2 study that used tocilizumab to reduce toxicities with immune checkpoint inhibitors in melanoma.
Insight on Treating Patients With Melanoma With Brain Metastases
Panelists discuss how treating patients with melanoma and brain metastases requires a multidisciplinary approach, emphasizing the role of immunotherapy, targeted therapy, and local treatments, while considering factors like the extent of metastasis and patient-specific factors.
Cutaneous Melanoma Risk Elevated for Survivors of Specific Cancers
MONDAY, Dec. 23, 2024 (HealthDay News) — Specific cancers are associated with an increased risk for developing subsequent cutaneous melanoma, according to a study published in the January issue of JID Innovations.